Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML)

Clinical Lymphoma, Myeloma and Leukemia

Volumn 16, Issue 4, 2016, Pages 213-222.e2

  Pemmaraju, Naveen ^a   Kantarjian, Hagop ^a   Ravandi, Farhad ^a   Nogueras Gonzalez, Graciela M ^a   Huang, Xuelin ^a   O'Brien, Susan ^a   Wierda, William ^a   Garcia Manero, Guillermo ^a   Thomas, Deborah ^a   Pierce, Sherry ^a   Verstovsek, Srdan ^a   Borthakur, Gautam ^a   Cortes, Jorge ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adherence; Diploid cytogenetics; FLT3 mutation; Older adult; Pediatric

Indexed keywords

CORE BINDING FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; GENE MUTATION; HODGKIN DISEASE; HUMAN; KARYOTYPE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PALLIATIVE THERAPY; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT RESPONSE; YOUNG ADULT; FEMALE; LEUKEMIA, MYELOID, ACUTE; MALE; MORTALITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84961782241     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.1016/j.clml.2015.12.010     Document Type: Article

References (50)

1. A.R. Derolf, S.Y. Kristinsson, T.M. Andersson, O. Landgren, P.W. Dickman, and M. Bjorkholm Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005 Blood 113 2009 3666 3672
2. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
3. F.R. Appelbaum, H. Gundacker, D.R. Head, and et al. Age and acute myeloid leukemia Blood 107 2006 3481 3485
4. F. Ravandi, A.K. Burnett, E.D. Agura, and H.M. Kantarjian Progress in the treatment of acute myeloid leukemia Cancer 110 2007 1900 1910
5. A. Burnett, M. Wetzler, and B. Lowenberg Therapeutic advances in acute myeloid leukemia J Clin Oncol 29 2011 487 494
6. A. Bleyer, R. Barr, B. Hayes-Lattin, D. Thomas, C. Ellis, and B. Anderson The distinctive biology of cancer in adolescents and young adults Nat Rev Cancer 8 2008 288 298
7. C. Schmidt Lack of progress in teen and young adult cancers concerns researchers, prompts study J Natl Cancer Inst 98 2006 1760 1763
8. A. Bleyer, S.E. Siegel, P.F. Coccia, W. Stock, and N.L. Seibel Children, adolescents, and young adults with leukemia: the empty half of the glass is growing J Clin Oncol 30 2012 4037 4038 author reply: 4038-9
9. W.A. Wood, and S.J. Lee Malignant hematologic diseases in adolescents and young adults Blood 117 2011 5803 5815
10. Y. Ofran, and J.M. Rowe Acute myeloid leukemia in adolescents and young adults: challenging aspects Acta Haematol 132 2014 292 297
11. W. Stock Adolescents and young adults with acute lymphoblastic leukemia Hematology Am Soc Hematol Educ Program 2010 2010 21 29
12. A.S. Advani, S.P. Hunger, and A.K. Burnett Acute leukemia in adolescents and young adults Semin Oncol 36 2009 213 226
13. D. Pulte, A. Gondos, and H. Brenner Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005 Cancer 115 2009 4973 4979
14. D. Pulte, A. Gondos, and H. Brenner Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century Blood 113 2009 1408 1411
15. U. Creutzig, M.M. van den Heuvel-Eibrink, B. Gibson, and et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel Blood 120 2012 3187 3205
16. J.E. Rubnitz, B. Gibson, and F.O. Smith Acute myeloid leukemia Hematol Oncol Clin North Am 24 2010 35 63
17. G.J. Kaspers, and C.M. Zwaan Pediatric acute myeloid leukemia: towards high-quality cure of all patients Haematologica 92 2007 1519 1532
18. N. Daver, T. Liu Dumlao, F. Ravandi, and et al. Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapy Clin Lymphoma Myeloma Leuk 13 2013 435 440
19. J.C. Uitdehaag, F. Verkaar, H. Alwan, J. de Man, R.C. Buijsman, and G.J. Zaman A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets Br J Pharmacol 166 2012 858 876
20. D. Grimwade, R.K. Hills, A.V. Moorman, and et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials Blood 116 2010 354 365
21. P. Brown, E. McIntyre, R. Rau, and et al. The incidence and clinical significance of nucleophosmin mutations in childhood AML Blood 110 2007 979 985
22. U. Creutzig, T. Buchner, M.C. Sauerland, and et al. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A Cancer 112 2008 562 571
23. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
24. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
25. S. Morgan, S. Davies, S. Palmer, and M. Plaster Sex, drugs, and rock 'n' roll: caring for adolescents and young adults with cancer J Clin Oncol 28 2010 4825 4830
26. G.J. Veal, C.M. Hartford, and C.F. Stewart Clinical pharmacology in the adolescent oncology patient J Clin Oncol 28 2010 4790 4799
27. M.M. Gramatges, and K.R. Rabin The adolescent and young adult with cancer: state of the art- acute leukemias Curr Oncol Rep 15 2013 317 324
28. C.L. Treadgold, and A. Kuperberg Been there, done that, wrote the blog: the choices and challenges of supporting adolescents and young adults with cancer J Clin Oncol 28 2010 4842 4849
29. P. Butow, S. Palmer, A. Pai, B. Goodenough, T. Luckett, and M. King Review of adherence-related issues in adolescents and young adults with cancer J Clin Oncol 28 2010 4800 4809
30. J. Levine, A. Canada, and C.J. Stern Fertility preservation in adolescents and young adults with cancer J Clin Oncol 28 2010 4831 4841
31. E.E. Kent, L.S. Sender, R.A. Morris, and et al. Multilevel socioeconomic effects on quality of life in adolescent and young adult survivors of leukemia and lymphoma Qual Life Res 22 2013 1339 1351
32. N. Pemmaraju, and J. Cortes Chronic myeloid leukemia in adolescents and young adults: patient characteristics, outcomes and review of the literature Acta Haematol 132 2014 298 306
33. S. Wein, S. Pery, and A. Zer Role of palliative care in adolescent and young adult oncology J Clin Oncol 28 2010 4819 4824
34. N. Pemmaraju, H. Kantarjian, J. Shan, and et al. Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy Haematologica 97 2012 1029 1035
35. A. Ferrari, M. Montello, T. Budd, and A. Bleyer The challenges of clinical trials for adolescents and young adults with cancer Pediatr Blood Cancer 50 2008 1101 1104
36. M.E. Burke, K. Albritton, and N. Marina Challenges in the recruitment of adolescents and young adults to cancer clinical trials Cancer 110 2007 2385 2393
37. P.F. Coccia, A.S. Pappo, J. Altman, and et al. Adolescent and young adult oncology, version 2.2014 J Natl Compr Canc Netw 12 2014 21 32 quiz: 32
38. A. Bleyer, T. Budd, and M. Montello Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials Cancer 107 2006 1645 1655
39. A. Bleyer, A. Viny, and R. Barr Cancer in 15- to 29-year-olds by primary site Oncologist 11 2006 590 601
40. D. Pulte, A. Gondos, and H. Brenner Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010 Ann Oncol 21 2010 335 341
41. K. Horibe, I. Tsukimoto, and R. Ohno Clinicopathologic characteristics of leukemia in Japanese children and young adults Leukemia 15 2001 1256 1261
42. J. Canner, T.A. Alonzo, J. Franklin, and et al. Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group Cancer 119 2013 4162 4169
43. W.G. Woods, A.R. Franklin, T.A. Alonzo, and et al. Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials Cancer 119 2013 4170 4179
44. K. Takahashi, H. Kantarjian, N. Pemmaraju, and et al. Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD Br J Haematol 161 2013 659 666
45. N. Pemmaraju, H. Kantarjian, G. Garcia-Manero, and et al. Improving outcomes for patients with acute myeloid leukemia in first relapse: a single center experience Am J Hematol 90 2015 27 30
46. F.M. Abu-Duhier, A.C. Goodeve, G.A. Wilson, and et al. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group Br J Haematol 111 2000 190 195
47. H. Kiyoi, T. Naoe, Y. Nakano, and et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia Blood 93 1999 3074 3080
48. W.J. Rombouts, I. Blokland, B. Lowenberg, and R.E. Ploemacher Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene Leukemia 14 2000 675 683
49. K. Dohner, R.F. Schlenk, M. Habdank, and et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations Blood 106 2005 3740 3746
50. N. Pemmaraju, H. Kantarjian, M. Andreeff, J. Cortes, and F. Ravandi Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia Expert Opin Investig Drugs 23 2014 943 954